ELIGO BIOSCIENCE 

 THE MICROBIOME COMPANY 

From lab to startup

Eligo Bioscience was created in 2014 based on the research from the Lu Lab (MIT) and the Marraffini Lab (Rockefeller University), which was later published in Nature Biotechnology
Laureate of the Worldwide Innovation Challenge, Eligo was incubated at the Institut Pasteur in Paris. 

Our founders

Dr. David Bikard

• Tenure-track Professor at Institut Pasteur, Synthetic Biology Laboratory
• Travey K. Lee Award
• Bettencourt-Schuller Young Scientist Award

Dr. Xavier Duportet

• Former INRIA & MIT PhD student
• Kairos 50, MIT TR35, French Innovator of the Year
• Norbert Ségard Foundation Grand Prize Award
• Forbes 30 Under 30 in Science & Healthcare

Prof. Timothy Lu, MD-PhD

• Associate Professor of Biological Engineering, Electrical Engineering, and Computer Science at MIT
• Cofounder Synlogic & Sample6
• NIH New Innovator Award, MIT TR35
• Presidential Early Career Award

Prof. Luciano Marraffini

• Associate Professor at Rockefeller University, Laboratory of Bacteriology
• Cofounder Intellia Therapeutics
• CRISPR seminal inventor
• NIH New Innovator Award
• Cell 40 Under 40, Blavatnik National Award

Our Awards & Grants

A strong international 
and 
interdisciplinary team

We have assembled a team of extremely talented and experienced scientists and executives from the best institutions worldwide to translate our research into useful products.

Meet our team

null

David Bikard, PhD

Chief Scientific Officer
Board Member

null

Antoine Decrulle, PhD

Synthetic Biology

null

Xavier Duportet, PhD

Chief Executive Officer
Chairman

null

Sebastien Enault, M.Eng

Business Development

null

Bertrand Lellouche

Chief Financial Officer

null

Nathalie Lenfant

Executive Assistant

null

Erica Lieberman, BS

Discovery & Automation

null

Igor Stzepourginski, PhD

Operations & Preclinical

null

Jesus Fernandez-Rodriguez, PhD

Synthetic Biology

null

Matthieu Galtier, PhD

Animal Models

null

Sebastien Groyer, PhD

Board Member

null

Jean-Pierre Lehner, PhD

Board Member

Meet our investors

With over €600m in assets under management as of the end of 2015, Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in the life sciences field across Europe and North America, and in digital technologies in France and Germany.